Bicara Therapeutics BCAX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's total liabilities?
- Bicara Therapeutics (BCAX) reported total liabilities of $39.64M in Q1 2026.
- How has Bicara Therapeutics's total liabilities changed year-over-year?
- Bicara Therapeutics's total liabilities increased by 107.3% year-over-year, from $19.12M to $39.64M.
- What is the long-term trend for Bicara Therapeutics's total liabilities?
- Over 2 years (2023 to 2025), Bicara Therapeutics's total liabilities has grown at a 38.2% compound annual growth rate (CAGR), from $15.47M to $29.54M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.